Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening

The hepatic bile acid transporter Na⁺/taurocholate co-transporting polypeptide (NTCP) was identified in 2012 as the high-affinity hepatic receptor for the hepatitis B and D viruses (HBV/HDV). Since then, this carrier has emerged as promising drug target for HBV/HDV virus entry inhibitors,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Michael Kirstgen, Simon Franz Müller, Kira Alessandra Alicia Theresa Lowjaga, Nora Goldmann, Felix Lehmann, Sami Alakurtti, Jari Yli-Kauhaluoma, Karl-Heinz Baringhaus, Reimar Krieg, Dieter Glebe, Joachim Geyer
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-07-01
Saila:	Viruses
Gaiak:	HBV HDV NTCP entry inhibitor QSAR pharmacophore
Sarrera elektronikoa:	https://www.mdpi.com/1999-4915/13/8/1489
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!